{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:38:48Z","timestamp":1790069928490,"version":"4.0.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the development and reform commission of Jilin province","award":["2014Y090"],"award-info":[{"award-number":["2014Y090"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00277-018-3259-z","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T12:30:15Z","timestamp":1518870615000},"page":"563-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents"],"prefix":"10.1007","volume":"97","author":[{"given":"Shunan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"3259_CR1","volume-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of hematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon","edition":"4"},{"issue":"20","key":"3259_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"issue":"5","key":"3259_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","volume":"38","author":"F Julia","year":"2014","unstructured":"Julia F, Dalle S, Duru G, Balme B, Vergier B, Ortonne N, Vignon-Pennamen MD, Costes-Martineau V, Lamant L, Dalac S, Delattre C, D\u00e9chelotte P, Courville P, Carlotti A, De Muret A, Fraitag S, Levy A, Mitchell A, Petrella T (2014) Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol 38(5):673\u2013680. https:\/\/doi.org\/10.1097\/PAS.0000000000000156","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"3259_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.2012.072645","volume":"98","author":"L Pagano","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A, Fisogni S, Carluccio P, Mannelli F, Lunghi M, Pica G, Onida F, Cattaneo C, Piccaluga PP, Di Bona E, Todisco E, Musto P, Spadea A, D'Arco A, Pileri S, Leone G, Amadori S, Facchetti F, GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell'Adulto, Acute Leukemia Working Party) (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98(2):239\u2013246. https:\/\/doi.org\/10.3324\/haematol.2012.072645","journal-title":"Haematologica"},{"issue":"3","key":"3259_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bjd.12412","volume":"169","author":"F Julia","year":"2013","unstructured":"Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dereure O, Wetterwald M, d'Incan M, Grange F, Cornillon J, Tertian G, Maubec E, Saiag P, Barete S, Templier I, Aubin F, Dalle S (2013) Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol 169(3):579\u2013586. https:\/\/doi.org\/10.1111\/bjd.12412","journal-title":"Br J Dermatol"},{"issue":"1","key":"3259_CR6","first-page":"58","volume":"89","author":"C Bueno","year":"2004","unstructured":"Bueno C, Almeida J, Lucio P, Marco J, Garcia R, de Pablos JM, Parreira A, Ramos F, Ruiz-Cabello F, Suarez-Vilela D, San Miguel JF, Orfao A (2004) Incidence and characteristics of CD4(+)\/HLA DRhi dendritic cell malignancies. Haematologica 89(1):58\u201369","journal-title":"Haematologica"},{"issue":"1","key":"3259_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1182\/asheducation-2016.1.16","volume":"2016","author":"JM Sullivan","year":"2016","unstructured":"Sullivan JM, Rizzieri DA (2016) Treatment of blastic plasmacytoid dendritic cell neoplasm. Hematol Am Soc Hematol Educ Program 2016(1):16\u201323. https:\/\/doi.org\/10.1182\/asheducation-2016.1.16","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"3259_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.12659\/AJCR.903059","volume":"18","author":"BR Cmds","year":"2017","unstructured":"Cmds BR, Cjd SJ, Lac L, Mjr GA, Ns A, Afl C, Ms M, Vmds G, Amc SB, Jas Q, Nb DS (2017) Blastic plasmacytoid dendritic cell neoplasm with pulmonary involvement and atypical skin lesion. Am J Case Rep 18:692\u2013695. https:\/\/doi.org\/10.12659\/AJCR.903059","journal-title":"Am J Case Rep"},{"issue":"1","key":"3259_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.leukres.2011.07.033","volume":"36","author":"MJ Rauh","year":"2012","unstructured":"Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, Liesveld J, Ryan DH, Burack WR, Bennett JM (2012) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review. Leuk Res 36(1):81\u201386. https:\/\/doi.org\/10.1016\/j.leukres.2011.07.033","journal-title":"Leuk Res"},{"issue":"4","key":"3259_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jdcr.2017.03.015","volume":"3","author":"I Amitay-Laish","year":"2017","unstructured":"Amitay-Laish I, Sundram U, Hoppe RT, Hodak E, Medeiros BC, Kim YH (2017) Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: a subset with possible durable remission without transplantation. JAAD Case Rep 3(4):310\u2013315. https:\/\/doi.org\/10.1016\/j.jdcr.2017.03.015","journal-title":"JAAD Case Rep"},{"issue":"4","key":"3259_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5021\/ad.2017.29.4.501","volume":"29","author":"SH Kong","year":"2017","unstructured":"Kong SH, Han SH, Suh HS, Choi YS (2017) Blastic plasmacytoid dendritic cell neoplasm presenting as erythematous nodules with gallbladder involvement. Ann Dermatol 29(4):501\u2013503. https:\/\/doi.org\/10.5021\/ad.2017.29.4.501","journal-title":"Ann Dermatol"},{"issue":"2","key":"3259_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2340\/00015555-2515","volume":"97","author":"L Garc\u00eda-Colmenero","year":"2016","unstructured":"Garc\u00eda-Colmenero L, Gallardo F, Salar A, Alvarez-Larr\u00e1n A, Colomo L, Pujol RM (2016) Blastic plasmacytoid dendritic cell neoplasm associated with dystrophic Xanthomatosis after chemotherapy. Acta Derm Venereol 97(2):293\u2013294. https:\/\/doi.org\/10.2340\/00015555-2515","journal-title":"Acta Derm Venereol"},{"key":"3259_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/MPH.0000000000000951","volume":"7","author":"BD Rajkumari","year":"2017","unstructured":"Rajkumari BD, Munikoty V, Sreedharanunni S, Jain R, Sachdeva MUS, Varma N (2017) Childhood blastic plasmacytoid dendritic cell neoplasm mimicking acute rheumatic fever: report of an unusual clinical presentation and review of literature. J Pediatr Hematol Oncol 7:709\u2013715. https:\/\/doi.org\/10.1097\/MPH.0000000000000951","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"3259_CR14","doi-asserted-by":"publisher","first-page":"10174","DOI":"10.18632\/oncotarget.7101","volume":"7","author":"MM Lourdes","year":"2016","unstructured":"Lourdes MM, Julia A, Helena P, Eva GB, Pilar B, Teresa G, Cecilia H, Jose AQ, Elena PC, Violeta M, Natalia A, Carlota C, Rodolfo A, Mar\u00eda DC, Alberto O (2016) Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy. Oncotarget 7(9):10174\u201310181. https:\/\/doi.org\/10.18632\/oncotarget.7101","journal-title":"Oncotarget"},{"issue":"8","key":"3259_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jamaneurol.2015.0830","volume":"72","author":"WF Qubty","year":"2015","unstructured":"Qubty WF, Al-Kali A, Jones LK Jr (2015) Leukemic polyradiculopathy due to blastic plasmacytoid dendritic cell neoplasm. JAMA Neurol 72(8):938\u2013939. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0830","journal-title":"JAMA Neurol"},{"issue":"5","key":"3259_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00277-017-2947-4","volume":"96","author":"A Tzankov","year":"2017","unstructured":"Tzankov A, Hebeda K, Kremer M, Leguit R, Orazi A, van der Walt J, Gianelli U (2017) Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th meeting of the European Association for Haematopathology (EAHP) organized by the European bone marrow working group, Basel 2016. Ann Hematol 96(5):765\u2013777. https:\/\/doi.org\/10.1007\/s00277-017-2947-4","journal-title":"Ann Hematol"},{"issue":"4","key":"3259_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/107327481402100404","volume":"21","author":"W Riaz","year":"2014","unstructured":"Riaz W, Zhang L, Horna P, Sokol L (2014) Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy. Cancer Control 21(4):279\u2013289. https:\/\/doi.org\/10.1177\/107327481402100404","journal-title":"Cancer Control"},{"issue":"22","key":"3259_CR18","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.18632\/oncotarget.4146","volume":"6","author":"MM Lourdes","year":"2015","unstructured":"Lourdes MM, Antonio L, Belen V, Maria DC, Antonio SR, Silvia IF, Margarida L, Sergio A, Berta V, Pilar M, Ana F, Jorge C, Francisco RC, Josefa MB, Amparo S, Neus V, Alberto O, Julia A (2015) Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile. Oncotarget 6(22):19204\u201319216. https:\/\/doi.org\/10.18632\/oncotarget.4146","journal-title":"Oncotarget"},{"issue":"5","key":"3259_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/ajcp\/aqx012","volume":"147","author":"N Yigit","year":"2017","unstructured":"Yigit N, Suarez LF, Roth LG, Orazi A, Tam W (2017) CD4-negative variant of cutaneous blastic plasmacytoid dendritic cell neoplasm with a novel PBRM1 mutation in an 11-year-old girl. Am J Clin Pathol 147(5):453\u2013460. https:\/\/doi.org\/10.1093\/ajcp\/aqx012","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"3259_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3960\/jslrt.52.107","volume":"52","author":"Y Takiuchi","year":"2012","unstructured":"Takiuchi Y, Maruoka H, Aoki K, Kato A, Ono Y, Nagano S, Arima H, Inoue D, Mori M, Tabata S, Yanagita S, Matsushita A, Nishio M, Imai Y, Imai Y, Ito K, Fujita H, Kadowaki N, Ishikawa T, Takahashi T (2012) Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm lacking skin lesion: a borderline case between acute monocytic leukemia. J Clin Exp Hematop 52(2):107\u2013111. https:\/\/doi.org\/10.3960\/jslrt.52.107","journal-title":"J Clin Exp Hematop"},{"issue":"5","key":"3259_CR21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3904\/kjim.2015.406","volume":"32","author":"HS Kim","year":"2017","unstructured":"Kim HS, Kim HJ, Kim SH, Choi JY, Ko YH, Kim WS, Jung CW, Kim SJ (2017) Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea. Korean J Intern Med 32(5):890\u2013899. https:\/\/doi.org\/10.3904\/kjim.2015.406","journal-title":"Korean J Intern Med"},{"issue":"4","key":"3259_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1182\/blood-2012-08-447599","volume":"121","author":"S Montes-Moreno","year":"2013","unstructured":"Montes-Moreno S, Ramos-Medina R, Mart\u00ednez-L\u00f3pez A, Barrionuevo Cornejo C, Parra Cubillos A, Quintana-Truyenque S, Rodriguez Pinilla SM, Pajares R, Sanchez-Verde L, Martinez-Torrecuadrada J, Roncador G, Piris MA (2013) SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms. Blood 121(4):643\u2013647. https:\/\/doi.org\/10.1182\/blood-2012-08-447599","journal-title":"Blood"},{"issue":"1","key":"3259_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamadermatol.2013.7141","volume":"150","author":"KA Salva","year":"2014","unstructured":"Salva KA, Haemel AK, Pincus LB, Liu J, Sundram U, Guitart J, Longley BJ, Wood GS (2014) Expression of CD31\/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms. JAMA Dermatol 150(1):73\u201376. https:\/\/doi.org\/10.1001\/jamadermatol.2013.7141","journal-title":"JAMA Dermatol"},{"issue":"5","key":"3259_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","volume":"145","author":"F Garnache-Ottou","year":"2009","unstructured":"Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadi\u00e9 M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V, Macintyre E, Bene MC, Saas P, Jacob MC, GOELAMS and GEIL study (2009) Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 145(5):624\u2013636. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07679.x","journal-title":"Br J Haematol"},{"issue":"17","key":"3259_CR25","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1182\/blood-2011-03-337501","volume":"118","author":"M Lucioni","year":"2011","unstructured":"Lucioni M, Novara F, Fiandrino G, Riboni R, Fanoni D, Arra M, Venegoni L, Nicola M, Dallera E, Arcaini L, Onida F, Vezzoli P, Travaglino E, Boveri E, Zuffardi O, Paulli M, Berti E (2011) Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood 118(17):4591\u20134594. https:\/\/doi.org\/10.1182\/blood-2011-03-337501","journal-title":"Blood"},{"issue":"11","key":"3259_CR26","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1182\/blood.V99.11.4154","volume":"99","author":"D Leroux","year":"2002","unstructured":"Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, Le M\u00e9e F, Plessis G, Talmant P, Gachard N, Uettwiller F, Pages MP, Mozziconacci MJ, Eclache V, Sibille C, Avet-Loiseau H, Lafage-Pochitaloff M (2002) CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Blood 99(11):4154\u20134159. https:\/\/doi.org\/10.1182\/blood.V99.11.4154","journal-title":"Blood"},{"issue":"4","key":"3259_CR27","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/jid.2009.369","volume":"130","author":"T Wiesner","year":"2010","unstructured":"Wiesner T, Obenauf AC, Cota C, Fried I, Speicher MR, Cerroni L (2010) Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms. J Invest Dermatol 130(4):1152\u20131157. https:\/\/doi.org\/10.1038\/jid.2009.369","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3259_CR28","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1038\/bcj.2015.26","volume":"5","author":"Y Nakamura","year":"2015","unstructured":"Nakamura Y, Kayano H, Kakegawa E, Miyazaki H, Nagai T, Uchida Y, Ito Y, Wakimoto N, Mori S, Bessho M (2015) Identification of SUPT3H as a novel 8q24\/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t (6;8) (p21; q24) translocation. Blood Cancer J 5(4):e301. https:\/\/doi.org\/10.1038\/bcj.2015.26","journal-title":"Blood Cancer J"},{"issue":"1","key":"3259_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/jclinpath-2013-201792","volume":"67","author":"Q Cao","year":"2014","unstructured":"Cao Q, Liu F, Niu G, Xue L, Han A (2014) Blastic plasmacytoid dendritic cell neoplasm with EWSR1 gene rearrangement. J Clin Pathol 67(1):90\u201392. https:\/\/doi.org\/10.1136\/jclinpath-2013-201792","journal-title":"J Clin Pathol"},{"issue":"4","key":"3259_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3892\/etm.2015.2236","volume":"9","author":"NA Gao","year":"2015","unstructured":"Gao NA, Wang XX, Sun JR, Yu WZ, Guo NJ (2015) Blastic plasmacytoid dendritic cell neoplasm with leukemic manifestation and ETV6 gene rearrangement: a case report. Exp Ther Med 9(4):1109\u20131112. https:\/\/doi.org\/10.3892\/etm.2015.2236","journal-title":"Exp Ther Med"},{"issue":"1","key":"3259_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/gcc.22119","volume":"53","author":"K Tokuda","year":"2014","unstructured":"Tokuda K, Eguchi-Ishimae M, Yagi C, Kawabe M, Moritani K, Niiya T, Tauchi H, Ishii E, Eguchi M (2014) CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm. Genes Chromosomes Cancer 53(1):78\u201389. https:\/\/doi.org\/10.1002\/gcc.22119","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"3259_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.cancergen.2015.04.011","volume":"208","author":"N Yang","year":"2015","unstructured":"Yang N, Huh J, Chung WS, Cho MS, Ryu KH, Chung HS (2015) KMT2A (MLL)-MLLT1, rearrangement in blastic plasmacytoid dendritic cell neoplasm. Cancer Genet 208(9):464\u2013467. https:\/\/doi.org\/10.1016\/j.cancergen.2015.04.011","journal-title":"Cancer Genet"},{"issue":"4","key":"3259_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/leu.2008.359","volume":"23","author":"F Jardin","year":"2009","unstructured":"Jardin F, Callanan M, Penther D, Ruminy P, Troussard X, Kerckaert JP, Figeac M, Parmentier F, Rainville V, Vaida I, Bertrand P, Duval AB, Picquenot JM, Chaperot L, Marolleau JP, Plumas J, Tilly H, Bastard C (2009) Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1\/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease. Leukemia 23(4):698\u2013707. https:\/\/doi.org\/10.1038\/leu.2008.359","journal-title":"Leukemia"},{"issue":"18","key":"3259_CR34","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1182\/blood-2013-01-451781","volume":"121","author":"O Abdelwahab","year":"2013","unstructured":"Abdelwahab O, Levine RL (2013) Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood 121(18):3563\u20133572. https:\/\/doi.org\/10.1182\/blood-2013-01-451781","journal-title":"Blood"},{"issue":"12","key":"3259_CR35","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/ajh.23567","volume":"88","author":"K Alayed","year":"2013","unstructured":"Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Medeiros LJ, Khoury JD (2013) TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow. Am J Hematol 88(12):1055\u20131061. https:\/\/doi.org\/10.1002\/ajh.23567","journal-title":"Am J Hematol"},{"issue":"4","key":"3259_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/leu.2013.283","volume":"28","author":"J Menezes","year":"2014","unstructured":"Menezes J, Acquadro F, Wiseman M, G\u00f3mez-L\u00f3pez G, Salgado RN, Talavera-Casa\u00f1as JG, Bu\u00f1o I, Cervera JV, Montes-Moreno S, Hern\u00e1ndez-Rivas JM, Ayala R, Calasanz MJ, Larrayoz MJ, Brichs LF, Gonzalez-Vicent M, Pisano DG, Piris MA, \u00c1lvarez S, Cigudosa JC (2014) Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm. Leukemia 28(4):823\u2013829. https:\/\/doi.org\/10.1038\/leu.2013.283","journal-title":"Leukemia"},{"issue":"15","key":"3259_CR37","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.18632\/oncotarget.2223","volume":"5","author":"A Stenzinger","year":"2014","unstructured":"Stenzinger A, Endris V, Pfarr N, Andrulis M, J\u00f6hrens K, Klauschen F, Siebolts U, Wolf T, Koch PS, Schulz M, Hartschuh W, Goerdt S, Lennerz JK, Wickenhauser C, Klapper W, Anagnostopoulos I, Weichert W (2014) Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm. Oncotarget 5(15):6404\u20136413. https:\/\/doi.org\/10.18632\/oncotarget.2223","journal-title":"Oncotarget"},{"issue":"5","key":"3259_CR38","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/leu.2017.38","volume":"31","author":"L Brunetti","year":"2017","unstructured":"Brunetti L, Di Battista V, Venanzi A, Schiavoni G, Martelli MP, Ascani S, Mecucci C, Tiacci E, Falini B (2017) Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin. Leukemia 31(5):1238\u20131240. https:\/\/doi.org\/10.1038\/leu.2017.38","journal-title":"Leukemia"},{"issue":"11","key":"3259_CR39","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.3324\/haematol.2017.172742","volume":"102","author":"L Wang","year":"2017","unstructured":"Wang L, Yang M, Zhang X, Yang C, Huang X, Wang Z, Jin J (2017) ARID1A mutation in blastic lasmacytoid dendritic cell neoplasm. Haematologica 102(11):e470\u2013e472. https:\/\/doi.org\/10.3324\/haematol.2017.172742","journal-title":"Haematologica"},{"key":"3259_CR40","doi-asserted-by":"publisher","unstructured":"(2016) BET inhibitors target blastic plasmacytoid dendritic cell neoplasms. Cancer Discov 7:11. https:\/\/doi.org\/10.1158\/2159-8290.CD-RW2016-226","DOI":"10.1158\/2159-8290.CD-RW2016-226"},{"issue":"5","key":"3259_CR41","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","volume":"99","author":"J Feuillard","year":"2002","unstructured":"Feuillard J, Jacob MC, Valensi F, Maynadi\u00e9 M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Dr\u00e9nou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, B\u00e9n\u00e9 MC (2002) Clinical and biologic features of CD4+ CD56+ malignancies. Blood 99(5):1556\u20131563. https:\/\/doi.org\/10.1182\/blood.V99.5.1556","journal-title":"Blood"},{"issue":"7","key":"3259_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bmt.1704215","volume":"32","author":"P Reimer","year":"2003","unstructured":"Reimer P, R\u00fcdiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, Konrad M\u00fcller-Hermelink H, Wilhelm M (2003) What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant 32(7):637\u2013646. https:\/\/doi.org\/10.1038\/sj.bmt.1704215","journal-title":"Bone Marrow Transplant"},{"key":"3259_CR43","doi-asserted-by":"crossref","unstructured":"Pemmaraju N, Thomas DA, Kantarjian H, O'Brien SM, Daver NG, Nazha A, Pierce S, GarciaManero G, Cortes JE, Faderl S (2012) Analysis of outcomes of patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN). J Clin Oncol 30:Abstract 6578","DOI":"10.1200\/jco.2012.30.15_suppl.6578"},{"issue":"4","key":"3259_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/ehm.12.33","volume":"5","author":"PP Piccaluga","year":"2012","unstructured":"Piccaluga PP, Paolini S, Sapienza MR, Pileri SA (2012) Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care? Expert Rev Hematol 5(4):353\u2013355. https:\/\/doi.org\/10.1586\/ehm.12.33","journal-title":"Expert Rev Hematol"},{"issue":"23","key":"3259_CR45","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1182\/blood-2015-01-621268","volume":"125","author":"T Aoki","year":"2015","unstructured":"Aoki T, Suzuki R, Kuwatsuka Y, Kako S, Fujimoto K, Taguchi J, Kondo T, Ohata K, Ito T, Kamoda Y, Fukuda T, Ichinohe T, Takeuchi K, Izutsu K, Suzumiya J (2015) Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm. Blood 125(23):3559\u20133562. https:\/\/doi.org\/10.1182\/blood-2015-01-621268","journal-title":"Blood"},{"issue":"3","key":"3259_CR46","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","volume":"121","author":"D Roos-Weil","year":"2013","unstructured":"Roos-Weil D, Dietrich S, Boumendil A, Polge E, Bron D, Carreras E, Iriondo Atienza A, Arcese W, Beelen DW, Cornelissen JJ, Kr\u00f6ger N, Milone G, Rossi G, Jardin F, Peters C, Rocha V, Sureda A, Mohty M, Dreger P, European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties (2013) Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood 121(3):440\u2013446. https:\/\/doi.org\/10.1182\/blood-2012-08-448613","journal-title":"Blood"},{"issue":"12","key":"3259_CR47","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00431-013-2248-4","volume":"173","author":"XD Zhong","year":"2014","unstructured":"Zhong XD, Wang LZ, Wang X, Chang J (2014) Diffuse lung metastases in a child with blastic plasmacytoid dendritic cell neoplasm and review. Eur J Pediatr 173(12):1667\u20131670. https:\/\/doi.org\/10.1007\/s00431-013-2248-4","journal-title":"Eur J Pediatr"},{"issue":"12","key":"3259_CR48","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/DAD.0000000000000348","volume":"37","author":"CM Nguyen","year":"2015","unstructured":"Nguyen CM, Stuart L, Skupsky H, Lee YS, Tsuchiya A, Cassarino DS (2015) Blastic Plasmacytoid dendritic cell neoplasm in the pediatric population: a case series and review of the literature. Am J Dermatopathol 37(12):924\u2013928. https:\/\/doi.org\/10.1097\/DAD.0000000000000348","journal-title":"Am J Dermatopathol"},{"issue":"8","key":"3259_CR49","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.bbmt.2010.12.706","volume":"17","author":"S Dietrich","year":"2011","unstructured":"Dietrich S, Andrulis M, Hegenbart U, Schmitt T, Bellos F, Martens UM, Meissner J, Kr\u00e4mer A, Ho AD, Dreger P (2011) Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant 17(8):1250\u20131254. https:\/\/doi.org\/10.1016\/j.bbmt.2010.12.706","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"3259_CR50","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","volume":"95","author":"AG Jegalian","year":"2010","unstructured":"Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010) Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 95(11):1873\u20131879. https:\/\/doi.org\/10.3324\/haematol.2010.026179","journal-title":"Haematologica"},{"issue":"3","key":"3259_CR51","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jaad.2007.12.012","volume":"58","author":"JJ Leitenberger","year":"2008","unstructured":"Leitenberger JJ, Berthelot CN, Polder KD, Pro B, McLaughlin P, Jones D, Duvic M (2008) CD4+ CD56+ hematodermic\/plasmacytoid dendritic cell tumor with response to pralatrexate. J Am Acad Dermatol 58(3):480\u2013488. https:\/\/doi.org\/10.1016\/j.jaad.2007.12.012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3259_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ejh.12294","volume":"93","author":"K Laribi","year":"2014","unstructured":"Laribi K, Denizon N, Ghnaya H, Atlassi M, Besan\u00e7on A, Pineau-Vincent F, Gaulard P, Petrella T (2014) Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine. Eur J Haematol 93(1):81\u201385. https:\/\/doi.org\/10.1111\/ejh.12294","journal-title":"Eur J Haematol"},{"issue":"11","key":"3259_CR53","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3109\/10428194.2016.1160084","volume":"57","author":"R Khwaja","year":"2016","unstructured":"Khwaja R, Daly A, Wong M, Mah\u00e9 E, Cerquozzi S, Owen C (2016) Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases. Leuk Lymphoma 57(11):2720\u20132722. https:\/\/doi.org\/10.3109\/10428194.2016.1160084","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"3259_CR54","first-page":"2603","volume":"6","author":"K-J Sugimoto","year":"2013","unstructured":"Sugimoto K-J, Shimada A, Yamaguchi N, Imai H, Wakabayashi M, Sekiguchi Y, Izumi H, Ota Y, Komatsu N, Noguchi M (2013) Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose De VIC therapy and radiation therapy: a case report and review of the literature. Int J Clin Exp Pathol 6(11):2603\u20132608","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"3259_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/bjd.13232","volume":"172","author":"C Vassallo","year":"2015","unstructured":"Vassallo C, Pezzini C, Carugno A, Derlino F, Croci G, Paulli M, Borroni G (2015) Cutaneous blastic plasmacytoid dendritic cell neoplasm: successful palliative treatment with oral prednisone in an elderly patient. Br J Dermatol 172(1):298\u2013300. https:\/\/doi.org\/10.1111\/bjd.13232","journal-title":"Br J Dermatol"},{"key":"3259_CR56","doi-asserted-by":"publisher","first-page":"651906","DOI":"10.1155\/2011\/651906","volume":"2011","author":"A Steinberg","year":"2011","unstructured":"Steinberg A, Kansal R, Wong M, Lopez A, Lim S, Lopategui J, Lill M (2011) Good clinical response in a rare aggressive hematopoietic neoplasm: plasmacytoid dendritic cell leukemia with no cutaneous lesions responding to 4 donor lymphocyte infusions following transplant. Case Rep Transplant 2011:651906\u2013651904. https:\/\/doi.org\/10.1155\/2011\/651906","journal-title":"Case Rep Transplant"},{"issue":"6","key":"3259_CR57","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/bmt.2012.242","volume":"48","author":"M Unteregger","year":"2013","unstructured":"Unteregger M, Valentin A, Zinke-Cerwenka W, Troppan K, Deutsch A, Cerroni L, Linkesch W, Neumeister P (2013) Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm. Bone Marrow Transplant 48(6):799\u2013802. https:\/\/doi.org\/10.1038\/bmt.2012.242","journal-title":"Bone Marrow Transplant"},{"key":"3259_CR58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3324\/haematol.2014.111740","volume":"2015","author":"F Angelot-Delettre","year":"2015","unstructured":"Angelot-Delettre F, Roggy A, Frankel AE, Lamarthee B, Seilles E, Biichle S, Royer B, Deconinck E, Rowinsky EK, Brooks C, Bardet V, Benet B, Bennani H, Benseddik Z, Debliquis A, Lusina D, Roussel M, Solly F, Ticchioni M, Saas P, Garnache-Ottou F (2015) In vivo and in vitro sensitivity of blastic plasmacytoid dentritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent. Haematologica 2015:223\u2013230. https:\/\/doi.org\/10.3324\/haematol.2014.111740 .","journal-title":"Haematologica"},{"issue":"3","key":"3259_CR59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","volume":"124","author":"AE Frankel","year":"2014","unstructured":"Frankel AE, Woo JH, Ahn C, Pemmaraju N, Medeiros BC, Carraway HE, Frankfurt O, Forman SJ, Yang XA, Konopleva M, Garnache-Ottou F, Angelot-Delettre F, Brooks C, Szarek M, Rowinsky E (2014) Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood 124(3):385\u2013392. https:\/\/doi.org\/10.1182\/blood-2014-04-566737","journal-title":"Blood"},{"key":"3259_CR60","doi-asserted-by":"crossref","unstructured":"Shepro D, Miller M (2014) Gemcitabine in blastic plasmacytoid dendritic cell neoplasm (CD4+ CD56+ hematodermic neoplasm). Blood 124: Abstract 5457","DOI":"10.1182\/blood.V124.21.5457.5457"},{"issue":"2","key":"3259_CR61","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1158\/2159-8290.CD-16-0999","volume":"7","author":"J Montero","year":"2017","unstructured":"Montero J, Stephansky J, Cai T, Griffin GK, Cabal-Hierro L, Togami K, Hogdal LJ, Galinsky I, Morgan EA, Aster JC, Davids MS, LeBoeuf NR, Stone RM, Konopleva M, Pemmaraju N, Letai A, Lane AA (2017) Blastic Plasmacytoid dendritic cell neoplasm is dependent on BCL2 and sensitive to venetoclax. Cancer Discov 7(2):156\u2013164. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0999","journal-title":"Cancer Discov"},{"issue":"8","key":"3259_CR62","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/leu.2014.64","volume":"28","author":"MR Sapienza","year":"2014","unstructured":"Sapienza MR, Fuligni F, Agostinelli C, Tripodo C, Righi S, Laginestra MA, Pileri A Jr, Mancini M, Rossi M, Ricci F, Gazzola A, Melle F, Mannu C, Ulbar F, Arpinati M, Paulli M, Maeda T, Gibellini D, Pagano L, Pimpinelli N, Santucci M, Cerroni L, Croce CM, Facchetti F, Piccaluga PP, Pileri SA, AIRC 5xMille consortium \u2018Genetics-driven targeted management of lymphoid malignancies and the Italian Registry on Blastic Plasmacytoid Dendritic Cell Neoplasm (2014) Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. Leukemia 28(8):1606\u20131616. https:\/\/doi.org\/10.1038\/leu.2014.64","journal-title":"Leukemia"},{"issue":"19","key":"3259_CR63","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-11-0212","volume":"17","author":"A Agliano","year":"2011","unstructured":"Agliano A, Martin-Padura I, Marighetti P, Gregato G, Calleri A, Prior C, Redrado M, Calvo A, Bertolini F (2011) Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma\/blastic plasmacytoid dendritic cell neoplasm. Clin Cancer Res 17(19):6163\u20136173. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0212","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3259_CR64","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1002\/ajh.24696","volume":"92","author":"ML Ulrickson","year":"2017","unstructured":"Ulrickson ML, Puri A, Lindstrom S, Cassaday RD, De Padova N, Becker PS (2017) Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm. Am J Hematol 92(5):E75\u2013E77. https:\/\/doi.org\/10.1002\/ajh.24696","journal-title":"Am J Hematol"},{"issue":"11","key":"3259_CR65","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3324\/haematol.2017.169326","volume":"102","author":"L Philippe","year":"2017","unstructured":"Philippe L, Ceroi A, B\u00f4le-Richard E, Jenvrin A, Biichle S, Perrin S, Limat S, Bonnefoy F, Deconinck E, Saas P, Garnache-Ottou F, Angelot-Delettre F (2017) Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm. Haematologica 102(11):1861\u20131868. https:\/\/doi.org\/10.3324\/haematol.2017.169326","journal-title":"Haematologica"},{"issue":"7","key":"3259_CR66","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/leu.2017.101","volume":"31","author":"K Suzuki","year":"2017","unstructured":"Suzuki K, Suzuki Y, Hama A, Muramatsu H, Nakatochi M, Gunji M, Ichikawa D, Hamada M, Taniguchi R, Kataoka S, Murakami N, Kojima D, Sekiya Y, Nishikawa E, Kawashima N, Narita A, Nishio N, Nakazawa Y, Iwafuchi H, Watanabe KI, Takahashi Y, Ito M, Kojima S, Kato S, Okuno Y (2017) Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm. Leukemia 31(7):1629\u20131633. https:\/\/doi.org\/10.1038\/leu.2017.101","journal-title":"Leukemia"},{"issue":"7","key":"3259_CR67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/MPH.0000000000000964","volume":"39","author":"MJ Kim","year":"2017","unstructured":"Kim MJ, Nasr A, Kabir B, de Nanassy J, Tang K, Menzies-Toman D, Johnston D, El Demellawy D (2017) Pediatric blastic plasmacytoid dendritic cell neoplasm: a systematic literature review. J Pediatr Hematol Oncol 39(7):528\u2013537. https:\/\/doi.org\/10.1097\/MPH.0000000000000964","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"3259_CR68","doi-asserted-by":"publisher","first-page":"564","DOI":"10.5858\/arpa.2013-0101-RS","volume":"138","author":"Y Shi","year":"2014","unstructured":"Shi Y, Wang E (2014) Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. Arch Pathol Lab Med 138(4):564\u2013569. https:\/\/doi.org\/10.5858\/arpa.2013-0101-RS","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"3259_CR69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5021\/ad.2012.24.2.235","volume":"24","author":"T Pintoalmeida","year":"2012","unstructured":"Pintoalmeida T, Fernandes I, Sanches M, Lau C, Lima M, Alves R, Selores M (2012) A case of blastic plasmacytoid dendritic cell neoplasm. Ann Dermatol 24(2):235\u2013237. https:\/\/doi.org\/10.5021\/ad.2012.24.2.235","journal-title":"Ann Dermatol"},{"issue":"5","key":"3259_CR70","first-page":"8204","volume":"8","author":"N Ishibashi","year":"2015","unstructured":"Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Miura K, Hatta Y, Sugitani M (2015) Radiation therapy for cutaneous blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature. Int J Clin Exp Med 8(5):8204\u20138209","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"3259_CR71","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","volume":"15","author":"MW Bekkenk","year":"2004","unstructured":"Bekkenk MW, Jansen PM, Meijer CJ, Willemze R (2004) CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Onco 15(7):1097\u20131108. https:\/\/doi.org\/10.1093\/annonc\/mdh268","journal-title":"Ann Onco"},{"issue":"12","key":"3259_CR72","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/modpathol.3800679","volume":"19","author":"DL Jaye","year":"2006","unstructured":"Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D (2006) Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol 19(12):1555\u20131562. https:\/\/doi.org\/10.1038\/modpathol.3800679","journal-title":"Mod Pathol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3259-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3259-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3259-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T07:47:56Z","timestamp":1603871276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3259-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3259"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3259-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"2 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}